Creative Medical Technology Holdings Inc (CELZ)

[monte379]

We will see a lot more of those in the coming weeks. What folks have to remember is nothing is 100%, well, except death and taxes, right?

CaverStem® has been wildly successful from what we have seen. Very high percentages of success.

Even in Gershman trial patients, ones who were younger, had serious issues, and who do not respond to PDE5 inhibitors, had a good success rate.

The trail results will be out this summer proving that, and more current real world, real patient testimonials will be out as well.

CELZ is definitely going through some serious growing pains, some self induced IMHO, but there will be no changing the outcome.